ENAapplication/xmlftp://ftp.sra.ebi.ac.uk/vol1/fastq/SRR248/014/SRR24891014/SRR24891014.fastq.gzftp://ftp.sra.ebi.ac.uk/vol1/fastq/SRR248/017/SRR24891017/SRR24891017.fastq.gzftp://ftp.sra.ebi.ac.uk/vol1/fastq/SRR248/003/SRR24891003/SRR24891003.fastq.gzftp://ftp.sra.ebi.ac.uk/vol1/fastq/SRR248/012/SRR24891012/SRR24891012.fastq.gzftp://ftp.sra.ebi.ac.uk/vol1/fastq/SRR248/006/SRR24891006/SRR24891006.fastq.gzftp://ftp.sra.ebi.ac.uk/vol1/fastq/SRR248/001/SRR24891001/SRR24891001.fastq.gzftp://ftp.sra.ebi.ac.uk/vol1/fastq/SRR248/019/SRR24891019/SRR24891019.fastq.gzftp://ftp.sra.ebi.ac.uk/vol1/fastq/SRR248/008/SRR24891008/SRR24891008.fastq.gzftp://ftp.sra.ebi.ac.uk/vol1/fastq/SRR248/010/SRR24891010/SRR24891010.fastq.gzftp://ftp.sra.ebi.ac.uk/vol1/fastq/SRR248/007/SRR24891007/SRR24891007.fastq.gzftp://ftp.sra.ebi.ac.uk/vol1/fastq/SRR248/099/SRR24890999/SRR24890999.fastq.gzftp://ftp.sra.ebi.ac.uk/vol1/fastq/SRR248/018/SRR24891018/SRR24891018.fastq.gzftp://ftp.sra.ebi.ac.uk/vol1/fastq/SRR248/015/SRR24891015/SRR24891015.fastq.gzftp://ftp.sra.ebi.ac.uk/vol1/fastq/SRR248/004/SRR24891004/SRR24891004.fastq.gzftp://ftp.sra.ebi.ac.uk/vol1/fastq/SRR248/016/SRR24891016/SRR24891016.fastq.gzftp://ftp.sra.ebi.ac.uk/vol1/fastq/SRR248/009/SRR24891009/SRR24891009.fastq.gzftp://ftp.sra.ebi.ac.uk/vol1/fastq/SRR248/005/SRR24891005/SRR24891005.fastq.gzftp://ftp.sra.ebi.ac.uk/vol1/fastq/SRR248/002/SRR24891002/SRR24891002.fastq.gzftp://ftp.sra.ebi.ac.uk/vol1/fastq/SRR248/013/SRR24891013/SRR24891013.fastq.gzftp://ftp.sra.ebi.ac.uk/vol1/fastq/SRR248/011/SRR24891011/SRR24891011.fastq.gzftp://ftp.sra.ebi.ac.uk/vol1/fastq/SRR248/000/SRR24891000/SRR24891000.fastq.gzprimaryOK200GenomicsHarbin Medical Universityhttps://www.ebi.ac.uk/ena/browser/view/PRJNA982429Lignan enterolactone combined with gemcitabine inhibits epithelial ovarian cancerENAfalseLignan enterolactone combined with gemcitabine inhibits epithelial ovarian cancer2023-06-122023-06-12PRJNA982429